Our Experience in Carotid Endarterectomy. A Retrospective Study
Nuellari E & Prifti E - Our Experience in Carotid Endarterectomy. A Retrospective Study

Keywords

carotid endarterectomy
CEA
asymptomatic carotid stenosis.

How to Cite

Nuellari, E., & Prifti, E. (2024). Our Experience in Carotid Endarterectomy. A Retrospective Study. Albanian Journal of Trauma and Emergency Surgery, 8(1), 1351-1353. https://doi.org/10.32391/ajtes.v8i1.357

Abstract

Introduction: Carotid endarterectomy (CEA) operations have been more frequent in our practice in recent years, primarily for asymptomatic patients. In this article, we present our experience in this field.

Ojectives. Primary endpoints were death and stroke within 30 days of the procedure for asymptomatic patients. Secondary endpoints were acute myocardial infarction within 30 days of the process and peripheral nerve injury in all patients.

Patients and Method: This is a retrospective review of our recent experience. Data of  219 consecutive CEA, 177 in asymptomatic patients, operated on from January 2004- February 2009 by our equip are collected; all the patients were diagnosed with Duplex scanner and confirmed with multi-slice CT scanner angiography. Endarterectomy was performed either with loco-regional or general anesthesia with selective use of a shunt. Combined anti-aggregation with Clopidogrel and Aspirin was the rule at discharge. Patients were controlled for new neurological and cardiac events 30 days after the operation.

Results: One asymptomatic patient had a major stroke and died. In this group, the stroke and mortality rate is 1,69%. No peri-operative new acute myocardial infarction happened in any patient. Peripheral nerve lesions occurred in 2,7 %of all procedures.

Conclusions: CEA is a safe treatment for asymptomatic internal carotid stenoses in the hands of an experienced vascular surgeon. Our results for asymptomatic carotid stenoses are according to international guidelines' recommendations.

 

https://doi.org/10.32391/ajtes.v8i1.357
Nuellari E & Prifti E - Our Experience in Carotid Endarterectomy. A Retrospective Study

References

Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H, Viguier A, et al. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomized, multicentre trial. Lancet Neurol. 2008 Oct. 7 (10):885-92. [QxMD MEDLINE Link].

Wiesmann M, Schöpf V, Jansen O, Brückmann H. Stent-protected angioplasty versus carotid endarterectomy in patients with carotid artery stenosis: meta-analysis of randomized trial data. Eur Radiol. 2008 Dec. 18 (12):2956-66. [QxMD MEDLINE Link].

Brown K, Itum DS, Preiss J, Duwayri Y, Veeraswamy RK, Salam A, et al. Carotid artery stenting has an increased risk of external carotid artery occlusion compared with carotid endarterectomy. J Vasc Surg. 2015 Jan. 61 (1):119-24. [QxMD MEDLINE Link].

Hye RJ, Mackey A, Hill MD, Voeks JH, Cohen DJ, Wang K, et al. Incidence, outcomes, and effect on quality of life of cranial nerve injury in the Carotid Revascularization Endarterectomy versus Stenting Trial. J Vasc Surg. 2015 May. 61 (5):1208-14. [QxMD MEDLINE Link].

Brott TG, Calvet D, Howard G, Gregson J, Algra A, Becquemin JP, et al. Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis: a preplanned pooled analysis of individual patient data. Lancet Neurol. 2019 Apr. 18 (4):348-356. [QxMD MEDLINE Link].

Naazie IN, Magee GA, Mathlouthi A, Elsayed N, Dakour-Aridi H, Malas MB. Primary mechanism of stroke reduction in transcarotid artery revascularization is dynamic flow reversal. J Vasc Surg. 2021 Jul. 74 (1):187–194. [QxMD MEDLINE Link].

Kwolek CJ, Jaff MR, Leal JI, Hopkins LN, Shah RM, Hanover TM, et al. Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal. J Vasc Surg. 2015 Nov. 62 (5):1227-34. [QxMD MEDLINE Link].

Malas MB, Leal Lorenzo JI, Nejim B, Hanover TM, Mehta M, Kashyap V, et al. Analysis of the ROADSTER pivotal and extended-access cohorts shows excellent 1-year durability of transcarotid stenting with dynamic flow reversal. J Vasc Surg. 2019 Jun. 69 (6):1786-1796. [QxMD MEDLINE Link].

Schermerhorn ML, Liang P, Dakour-Aridi H, Kashyap VS, Wang GJ, Nolan BW, et al. In-hospital outcomes of transcarotid artery revascularization and carotid endarterectomy in the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg. 2020 Jan. 71 (1):87-95. [QxMD MEDLINE Link].

Malas MB, Dakour-Aridi H, Wang GJ, Kashyap VS, Motaganahalli RL, Eldrup-Jorgensen J, et al. Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg. 2019 Jan. 69 (1):92-103.e2. [QxMD MEDLINE Link].

Schermerhorn ML, Liang P, Eldrup-Jorgensen J, Cronenwett JL, Nolan BW, Kashyap VS, et al. Association of Transcarotid Artery Revascularization vs Transfemoral Carotid Artery Stenting With Stroke or Death Among Patients With Carotid Artery Stenosis. JAMA. 2019 Dec 17. 322 (23):2313-2322. [QxMD MEDLINE Link].

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.